Oral citalopram and reboxetine challenge tests before and after selective antidepressant treatment.
Moeller
Olaf
O
Hetzel
Guenter
G
Rothermundt
Matthias
M
Michael
Nikolaus
N
Nyhuis
Peter W
PW
Suslow
Thomas
T
Arolt
Volker
V
Erfurth
Andreas
A
D000928:Antidepressive Agents / Q000627:therapeutic use*; D015283:Citalopram / Q000008:administration & dosage / Q000494:pharmacology*; D003866:Depressive Disorder / Q000188:drug therapy*; D006801:Humans; D008995:Monoamine Oxidase / Q000378:metabolism; D009025:Morpholines / Q000008:administration & dosage / Q000494:pharmacology*; D011388:Prolactin / Q000378:metabolism*; D011446:Prospective Studies; D000077593:Reboxetine; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000494:pharmacology*; D013997:Time Factors
D000928:Antidepressive Agents; D015283:Citalopram; D008995:Monoamine Oxidase; D009025:Morpholines; D011388:Prolactin; D000077593:Reboxetine; D017367:Selective Serotonin Reuptake Inhibitors